These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
553 related items for PubMed ID: 26179774
1. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume. Kim TH, Ji YB, Song CM, Kim JY, Choi YY, Park JS, Tae K. World J Surg Oncol; 2015 Jul 16; 13():217. PubMed ID: 26179774 [Abstract] [Full Text] [Related]
2. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, Kasperbauer JL, Strome SE, Reading CC, Hay ID, Lowe VJ. Nucl Med Commun; 2007 May 16; 28(5):373-81. PubMed ID: 17414887 [Abstract] [Full Text] [Related]
3. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma. Kim BH, Kim SJ, Kim H, Jeon YK, Kim SS, Kim IJ, Kim YK. Nucl Med Commun; 2013 Sep 16; 34(9):868-76. PubMed ID: 23797273 [Abstract] [Full Text] [Related]
4. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules. Sebastianes FM, Cerci JJ, Zanoni PH, Soares J, Chibana LK, Tomimori EK, de Camargo RY, Izaki M, Giorgi MC, Eluf-Neto J, Meneghetti JC, Pereira MA. J Clin Endocrinol Metab; 2007 Nov 16; 92(11):4485-8. PubMed ID: 17684046 [Abstract] [Full Text] [Related]
5. The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination. Stangierski A, Woliński K, Czepczyński R, Czarnywojtek A, Lodyga M, Wyszomirska A, Janicka-Jedyńska M, Bączyk M, Ruchała M. PLoS One; 2014 Nov 16; 9(10):e109612. PubMed ID: 25296297 [Abstract] [Full Text] [Related]
6. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis. Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP. Biomed Mater Eng; 2014 Nov 16; 24(6):3091-103. PubMed ID: 25227018 [Abstract] [Full Text] [Related]
7. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Lin M, Wong C, Lin P, Shon IH, Cuganesan R, Som S. Hematol Oncol; 2011 Jun 16; 29(2):67-74. PubMed ID: 20635328 [Abstract] [Full Text] [Related]
8. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results. Naswa N, Sharma P, Soundararajan R, Patnecha M, Lata S, Kumar R, Malhotra A, Bal C. Diagn Interv Radiol; 2013 Jun 16; 19(4):294-8. PubMed ID: 23439252 [Abstract] [Full Text] [Related]
9. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients. Yoon JH, Cho A, Lee HS, Kim EK, Moon HJ, Kwak JY. Surgery; 2015 Nov 16; 158(5):1314-22. PubMed ID: 25958065 [Abstract] [Full Text] [Related]
10. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. Traugott AL, Dehdashti F, Trinkaus K, Cohen M, Fialkowski E, Quayle F, Hussain H, Davila R, Ylagan L, Moley JF. World J Surg; 2010 Jun 16; 34(6):1247-53. PubMed ID: 20140435 [Abstract] [Full Text] [Related]
11. The incidence of 18F-FDG PET/CT thyroid incidentalomas andthe prevalence of malignancy: a prospective study. Şencan Eren M, Özdoğan Ö, Gedik A, Ceylan M, Güray Durak M, Seçil M, Koçdor MA, Çömlekçi A, Durak H. Turk J Med Sci; 2016 Apr 19; 46(3):840-7. PubMed ID: 27513265 [Abstract] [Full Text] [Related]
12. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Hales NW, Krempl GA, Medina JE. Am J Otolaryngol; 2008 Apr 19; 29(2):113-8. PubMed ID: 18314022 [Abstract] [Full Text] [Related]
15. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis. Hu S, Zhang J, Cheng C, Liu Q, Sun G, Zuo C. Abdom Imaging; 2014 Dec 19; 39(6):1221-7. PubMed ID: 24913670 [Abstract] [Full Text] [Related]
16. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Mitchell JC, Grant F, Evenson AR, Parker JA, Hasselgren PO, Parangi S. Surgery; 2005 Dec 19; 138(6):1166-74; discussion 1174-5. PubMed ID: 16360405 [Abstract] [Full Text] [Related]
17. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach. Vriens D, Adang EM, Netea-Maier RT, Smit JW, de Wilt JH, Oyen WJ, de Geus-Oei LF. J Clin Endocrinol Metab; 2014 Sep 19; 99(9):3263-74. PubMed ID: 24873995 [Abstract] [Full Text] [Related]
18. Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group. Sager S, Vatankulu B, Erdogan E, Mut S, Teksoz S, Ozturk T, Sonmezoglu K, Kanmaz B. Endocrine; 2015 Sep 19; 50(1):138-45. PubMed ID: 25795290 [Abstract] [Full Text] [Related]
20. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results. Demir Ö, Köse N, Özkan E, Ünlütürk U, Aras G, Erdoğan MF. Nucl Med Commun; 2016 Jul 19; 37(7):715-20. PubMed ID: 26963467 [Abstract] [Full Text] [Related] Page: [Next] [New Search]